OncoSec Medical Incorporated
Symbol: ONCS
NASDAQ
0.2772
USDMarktpreis heute
-0.0457
P/E-Verhältnis
-0.0010
PEG-Verhältnis
1.65M
MRK Kapital
- 0.00%
DIV Rendite
OncoSec Medical Incorporated (ONCS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 41.19 | 12.3 | 46 | 20.4 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.other-current-assets | 10.25 | 2.9 | 3.2 | 2.5 | |||||||||||||||
balance-sheet.row.total-current-assets | 51.44 | 15.2 | 49.2 | 22.8 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 17.97 | 5.6 | 6.4 | 6.8 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 1.48 | 0.4 | 0.4 | 0 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1.48 | 0.4 | 0.4 | 0 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 2.29 | 0.6 | 0.3 | 0.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 21.74 | 6.6 | 7.1 | 7.1 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 73.18 | 21.9 | 56.3 | 29.9 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.short-term-debt | 6.22 | 2 | 2.1 | 1.5 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 14.19 | 4.1 | 5.2 | 6.4 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 19.24 | 4.6 | 5.9 | 8.2 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 34.19 | 9.1 | 10.2 | 6.4 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 16.39 | 5.2 | 6.1 | 6.4 | |||||||||||||||
balance-sheet.row.total-liab | 59.65 | 15.8 | 18.2 | 16 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.retained-earnings | -1158.6 | -286 | -251.8 | -206.6 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1.48 | 0.2 | -0.1 | 0 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1170.65 | 291.8 | 289.9 | 220.5 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 13.54 | 6.1 | 38.1 | 13.9 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 73.18 | 21.9 | 56.3 | 29.9 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 13.54 | 6.1 | 38.1 | 13.9 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 73.18 | - | - | - | |||||||||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-debt | 20.41 | 6.2 | 7.3 | 7.8 | |||||||||||||||
balance-sheet.row.net-debt | -20.78 | -6.1 | -38.6 | -12.5 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -29.39 | -34.2 | -45.2 | -42.3 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.94 | 1.1 | 1.1 | 1 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -0.8 | -0.1 | |||||||||||||||
cash-flows.row.stock-based-compensation | 1.28 | 1.6 | 5.1 | 3.5 | |||||||||||||||
cash-flows.row.change-in-working-capital | 2.05 | -1.2 | -2.5 | 3.8 | |||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.account-payables | -1.38 | -1.4 | -2.6 | 3.6 | |||||||||||||||
cash-flows.row.other-working-capital | 3.43 | 0.2 | 0.1 | 0.2 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0.12 | 0.6 | 0.5 | 0.9 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -24.99 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.24 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -0.26 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.debt-repayment | -1.15 | -1.3 | -0.6 | -0.1 | |||||||||||||||
cash-flows.row.common-stock-issued | 0.04 | 0 | 62.8 | 30 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 4.65 | 0.1 | 6 | -1.5 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 3.54 | -1.2 | 68.2 | 28.4 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.08 | -0.1 | 0 | 0 | |||||||||||||||
cash-flows.row.net-change-in-cash | -21.55 | -33.7 | 25.6 | -4.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 41.19 | 12.3 | 46 | 20.4 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 62.74 | 46 | 20.4 | 25.1 | |||||||||||||||
cash-flows.row.operating-cash-flow | -24.99 | -32.1 | -41.8 | -33.1 | |||||||||||||||
cash-flows.row.capital-expenditure | -0.24 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.free-cash-flow | -25.24 | -32.4 | -42.6 | -33.1 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 21.77 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 10.88 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0.06 | 0 | 0 | 0.2 | |||||||||||||||
income-statement-row.row.operating-expenses | 32.65 | 37 | 48.4 | 43.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 32.65 | 37 | 48.4 | 43.4 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.interest-expense | 0.05 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -0.07 | -0.5 | 0.8 | 0.3 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0.06 | 0 | 0 | 0.2 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -0.07 | -0.5 | 0.8 | 0.3 | |||||||||||||||
income-statement-row.row.interest-expense | 0.05 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.99 | 1.1 | 1.1 | 1.2 | |||||||||||||||
income-statement-row.row.ebitda-caps | -31.66 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | -32.65 | -37 | -48.4 | -43.4 | |||||||||||||||
income-statement-row.row.income-before-tax | -32.72 | -37.5 | -47.6 | -43.1 | |||||||||||||||
income-statement-row.row.income-tax-expense | -2.58 | -3.3 | -2.4 | -0.9 | |||||||||||||||
income-statement-row.row.net-income | -30.14 | -34.2 | -45.2 | -42.3 |
Häufig gestellte Frage
Wie hoch ist die OncoSec Medical Incorporated (ONCS) Gesamtvermögen?
OncoSec Medical Incorporated (ONCS) Gesamtvermögen ist 21878368.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.000.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -4.923.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.000.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.000.
Was ist der OncoSec Medical Incorporated (ONCS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -34179634.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 6174765.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 37012062.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 3683330.000.